$NHI

Mendelsohn D. Eric purchased $103K of NHI

Mendelsohn D. Eric (CEO and President) purchased 1,500 shares of NATIONAL HEALTH INVESTORS INC (NHI) at $68.84 ($0.10M total) on 2026-06-05.

Original reporting
SEC EDGAR · Mendelsohn D. Eric
Published Jun 5, 2026, 2:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 2:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NHI
Bullish
low confidence
Mentioned
$NHI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NHIBullishLow
01

Why it matters

The disclosure provides a datapoint on insider behavior but does not include new company fundamentals (no earnings, guidance, or transaction details beyond the buy).

02

Market read

Traders may treat this as a small sentiment input; it is unlikely to drive a major repricing without corroborating fundamental news.

03

What to watch

The filing does not reveal intent, timing constraints, or whether the purchase follows prior sales; traders should check for recent insider activity trends rather than one print.

Relevance 6/10Novelty 5/10Timing: Filed same day (2026-06-05) for an open-market buy at $68.84.

Background

The article is an SEC Form 4 insider transaction disclosure for National Health Investors (NHI).

Company-level read

Ticker impact

$NHIBullishLow confidence
Context

CEO/President Mendelsohn Eric bought 1,500 shares of National Health Investors on 2026-06-05 at $68.84 via open-market purchase.

Expected impact

Likely limited near-term impact; could modestly support sentiment if market is already watching insider activity.

Evidence & confidence

This is a routine SEC Form 4 insider transaction with no accompanying guidance, deal, or operational change disclosed.

Market effects

Minimal; insider buying in one REIT/healthcare landlord typically does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

Insider buys can be driven by diversification, liquidity planning, or pre-planned behavior rather than a new bullish thesis (notably, no 10b5-1 plan is cited).

Key entities

  • National Health Investors Inc

    Subject of the insider transaction: CEO/President Mendelsohn D. Eric purchased 1,500 shares on 2026-06-05.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NHIHighAI 8/10

NHI (NHI) Q2 2026 Earnings Call Transcript

NHI reported Q2 2026 earnings with net income per share up 45.6% to $1.15, driven by real estate sales. NAREIT FFO per share remained flat at $1.19, while normalized FFO per share decreased 2.5% due to transition costs. The company completed a $560M portfolio sale, increasing liquidity and reducing leverage. NHI plans to expand its senior housing operating portfolio (SHOP) to 40-50% of its total portfolio within three years, with $127.3M in new investments under signed letters of intent. The qua

$NHIMed

National Health Investors, Inc. Q2 2026 Earnings Call Summary

National Health Investors (NHI) reported Q2 2026 updates, including completion of the NHC portfolio sale on July 1 and plans to redeploy $334 million via Section 1031 exchanges. It said SHOP investment rose 137% to about $850 million and targets 40% to 50% of total NOI over three years. Management guided for 8% to 9% same-store SHOP NOI growth in 2H.

$NHIMed

NHI accelerates senior living pivot with completion of SNF-focused portfolio sale

National Health Investors (NHI) said it completed the sale of its National HealthCare Corp. portfolio of 32 skilled nursing facilities and three independent living communities, as part of a shift toward private-pay senior housing. NHI reported $273.2M YTD investments, including $212.0M in SHOP, and aims for SHOP to reach 40%-50% of its portfolio. It also hired a new COO and reported SHOP NOI up 188.5% YoY.

$NHIMed

National Health Investors Q2 Earnings Call Highlights

National Health Investors (NYSE:NHI) reported Q2 results with normalized FFO per share down 2.5% to $1.19 and funds available for distribution up 5.8% to $61.6 million. The board raised its quarterly dividend to $0.94 per share. NHI completed a $560 million sale of its NHC portfolio, expecting about a $541.6 million gain in Q3 and using proceeds for replacement properties and Section 1031 reinvestment.

$NHIMed

National Health Investors: Q2 Earnings Snapshot

National Health Investors Inc. (NHI) reported Q2 funds from operations of $57.8 million, or $1.19 per share, and net income of $55.6 million, or $1.15 per share, with revenue of $121.3 million. The REIT expects full-year funds from operations of $4.74 to $4.79 per share, according to the company.